107 related articles for article (PubMed ID: 15182890)
1. Residential treatment for smokeless tobacco use: a case series.
Ebbert JO; Dale LC; Vickers KS; Gauvin TR; Bunge NE; Hurt RD
J Subst Abuse Treat; 2004 Jun; 26(4):261-7. PubMed ID: 15182890
[TBL] [Abstract][Full Text] [Related]
2. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
Dale LC; Ebbert JO; Schroeder DR; Croghan IT; Rasmussen DF; Trautman JA; Cox LS; Hurt RD
Nicotine Tob Res; 2002 Aug; 4(3):267-74. PubMed ID: 12215235
[TBL] [Abstract][Full Text] [Related]
3. Nicotine lozenges for the treatment of smokeless tobacco use.
Ebbert JO; Dale LC; Severson H; Croghan IT; Rasmussen DF; Schroeder DR; Vander Weg MW; Hurt RD
Nicotine Tob Res; 2007 Feb; 9(2):233-40. PubMed ID: 17365754
[TBL] [Abstract][Full Text] [Related]
4. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
Ebbert JO; Dale LC; Patten CA; Croghan IT; Schroeder DR; Moyer TP; Hurt RD
Nicotine Tob Res; 2007 Jan; 9(1):43-52. PubMed ID: 17365735
[TBL] [Abstract][Full Text] [Related]
6. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.
Jacob P; Hatsukami D; Severson H; Hall S; Yu L; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1668-73. PubMed ID: 12496059
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of tobacco dependence.
Talwar A; Jain M; Vijayan VK
Med Clin North Am; 2004 Nov; 88(6):1517-34. PubMed ID: 15464111
[TBL] [Abstract][Full Text] [Related]
9. Bupropion SR for the treatment of smokeless tobacco use.
Dale LC; Ebbert JO; Glover ED; Croghan IT; Schroeder DR; Severson HH; Hurt RD
Drug Alcohol Depend; 2007 Sep; 90(1):56-63. PubMed ID: 17353101
[TBL] [Abstract][Full Text] [Related]
10. Tobacco cessation and nicotine replacement therapy for dental practice.
Christen AG; Jay SJ; Christen JA
Gen Dent; 2003; 51(6):525-32. PubMed ID: 15055649
[TBL] [Abstract][Full Text] [Related]
11. Measuring nicotine dependence among smokeless tobacco users.
Thomas JL; Ebbert JO; Patten CA; Dale LC; Bronars CA; Schroeder DR
Addict Behav; 2006 Sep; 31(9):1511-21. PubMed ID: 16386854
[TBL] [Abstract][Full Text] [Related]
12. Nicotine percentage replacement among smokeless tobacco users with nicotine patch.
Ebbert JO; Post JA; Moyer TP; Dale LC; Schroeder DR; Hurt RD
Drug Alcohol Depend; 2007 Jul; 89(2-3):223-6. PubMed ID: 17300878
[TBL] [Abstract][Full Text] [Related]
13. Clinical inquiries. What interventions can help patients stop using chewing tobacco?
Smith KD; Scott MA; Ketterman E; Smith PO
J Fam Pract; 2005 Apr; 54(4):368-9. PubMed ID: 15833231
[TBL] [Abstract][Full Text] [Related]
14. Bupropion and cognitive-behavioral therapy for smoking cessation in women.
Schmitz JM; Stotts AL; Mooney ME; Delaune KA; Moeller GF
Nicotine Tob Res; 2007 Jun; 9(6):699-709. PubMed ID: 17558827
[TBL] [Abstract][Full Text] [Related]
15. The impact of a free nicotine patch starter kit on quit rates in a state quit line.
Bush TM; McAfee T; Deprey M; Mahoney L; Fellows JL; McClure J; Cushing C
Nicotine Tob Res; 2008 Sep; 10(9):1511-6. PubMed ID: 19023843
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Cinciripini PM; Tsoh JY; Wetter DW; Lam C; de Moor C; Cinciripini L; Baile W; Anderson C; Minna JD
Exp Clin Psychopharmacol; 2005 Nov; 13(4):282-92. PubMed ID: 16366758
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from a patient-centered residential treatment plan for tobacco dependence.
Hodgkin JE; Sachs DP; Swan GE; Jack LM; Titus BL; Waldron SJ; Sachs BL; Brigham J
Mayo Clin Proc; 2013 Sep; 88(9):970-6. PubMed ID: 24001489
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a smokeless tobacco cessation program: a pilot study.
Eakin E; Severson H; Glasgow RE
NCI Monogr; 1989; (8):95-100. PubMed ID: 2716855
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
Killen JD; Robinson TN; Ammerman S; Hayward C; Rogers J; Stone C; Samuels D; Levin SK; Green S; Schatzberg AF
J Consult Clin Psychol; 2004 Aug; 72(4):729-35. PubMed ID: 15301658
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
Steinberg MB; Foulds J; Richardson DL; Burke MV; Shah P
Prev Med; 2006 Feb; 42(2):114-9. PubMed ID: 16375954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
